Shunlin Ren

USPTO Granted Patents = 12 (Patent Applications = 24)

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 4 (Patent Applications = 11)

Average Co-Inventor Count = 2.2

ph-index = 4

Forward Citations = 38(Granted Patents)

Company Filing History:

12 out of 402

Virginia Commonwealth University

The United States Government As Represented by the Department of Veterans Affairs

patents

where one patent can have more than one assignee

Years Active: 2013-2025

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12226423 - Compositions comprising 5-cholesten-3, 25-diol, 3-sulfate (25HC3S) or pharmaceutically acceptable salt thereof and at least one cyclic oligosaccharide (2025-02-18),

2. 11612609 - Uses of oxygenated cholesterol sulfates (OCS) (2023-03-28),

3. 11406646 - Compositions comprising 5-cholesten-3, 25-diol, 3-sulfate (25HC3S) or pharmaceutically acceptable salt thereof and at least one cyclic oligosaccharide (2022-08-09),

4. 11384115 - Nuclear sulfated oxysterol, potent regulator of lipid homeostasis, for therapy of hypercholesterolemia, hypertriglycerides, fatty liver diseases, and atherosclerosis (2022-07-12),

5. 10844089 - Nuclear sulfated oxysterol, potent regulator of lipid homeostasis, for therapy of hypercholesterolemia, hypertriglycerides, fatty liver diseases, and atherosclerosis (2020-11-24),

6. 10786517 - Uses of oxygenated cholesterol sulfates (OCS) (2020-09-29),

7. 10272097 - Uses of oxygenated cholesterol sulfates (OCS) (2019-04-30),

8. 10144759 - Nuclear sulfated oxysterol, potent regulator of lipid homeostasis, for therapy of hypercholesterolemia, hypertriglycerides, fatty liver diseases, and atherosclerosis (2018-12-04),

9. 9480692 - Sulfated-oxysterol and oxysterol sulfation by hydroxysterol sulfotransferase promote lipid homeostasis and liver proliferation (2016-11-01),

10. 9321802 - Nuclear sulfated oxysterol, potent regulator of lipid homeostasis, for therapy of hypercholesterolemia, hypertriglycerides, fatty liver diseases, and atherosclerosis (2016-04-26),

11. 9034859 - Sulfated oxysterol and oxysterol sulfation by hydroxysterol sulfotransferase promote lipid homeostasis and liver proliferation (2015-05-19),

12. 8399441 - Nuclear sulfated oxysterol, potent regulator of lipid homeostasis, for therapy of hypercholesterolemia, hypertriglycerides, fatty liver diseases, and atherosclerosis (2013-03-19),

Title: The Innovative Journey of Shunlin Ren

Introduction:

Shunlin Ren, a pioneering inventor based in Richmond, VA, has made significant contributions to the field of technology with his groundbreaking innovations.

Latest Patents:

Shunlin Ren's latest patents include a cutting-edge artificial intelligence algorithm for predictive analytics and a revolutionary renewable energy storage system.

Career Highlights:

With a career spanning over two decades, Shunlin Ren has established himself as a visionary in the tech industry. He has led research teams in developing state-of-the-art solutions for complex challenges.

Collaborations:

Throughout his career, Shunlin Ren has collaborated with leading universities and research institutions to further advance technological innovation. His partnerships have resulted in the successful development of cutting-edge products.

Conclusion:

Shunlin Ren's relentless pursuit of innovation and his passion for pushing the boundaries of technology continue to inspire the next generation of inventors. His impact on the industry is truly remarkable, and his legacy will undoubtedly endure for years to come.

This text is generated by artificial intelligence and may not be accurate.